High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
Cytarabine Injection - NPS MedicineWise
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
Application of Chemotherapy in Hematology Malignancies 林建廷 Dec 4, ppt download
Chemotherapeutic Agents. Introduction n Classification of Drugs n Cell-cycle specificity n Mechanism of Action n Indication n Side effects. - ppt download
X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition | Haematologica
Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... | Download Scientific Diagram
Cytarabine (Ara C, cytosine arabinoside)
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
Genetic factors influencing cytarabine therapy | Pharmacogenomics
Cytarabine ears – A side effect of cytarabine therapy | Semantic Scholar
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom? | Haematologica
Chemotherapy of acute leukemia with ara-C Estimated ara-C plasma... | Download Table
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis | PLOS ONE
PDF) Ara C face: Cytarabine related dermatological toxicity
7+3 (daunorubicin) for AML | ChemoExperts
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine - Wikiwand
